Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,192 stories indexed, page 119 of 154

๐Ÿ‡ฌ๐Ÿ‡งResearchroyalfree.nhs.uk

International Day of the Midwife - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
๐Ÿ‡ฌ๐Ÿ‡งResearchroyalfree.nhs.uk

Exciting new phase begins for North Mid UEC redevelopment - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
๐Ÿ‡ฌ๐Ÿ‡งResearchroyalfree.nhs.uk

Early success for new adult assessment model at Barnet Hospital - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
๐Ÿ‡ฌ๐Ÿ‡งResearchroyalfree.nhs.uk

Changes to our patient and visitor car parking charges - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
๐Ÿ‡ฌ๐Ÿ‡งResearchroyalfree.nhs.uk

Celebrating International Nurses Day - Royal Free London

Royal Free London NHS Foundation TrustOriginal source
๐Ÿ‡ณ๐Ÿ‡ฑResearchradboudumc.nl

Subscribe and/or submit

Radboudumc (Nijmegen)Original source
๐Ÿ‡ณ๐Ÿ‡ฑResearchradboudumc.nl

Horizon Europe collaboration opportunities with Institute of Science Tokyo

Radboudumc (Nijmegen)Original source
๐Ÿ‡ณ๐Ÿ‡ฑResearchradboudumc.nl

A promising European collaboration is placing neuromuscular patients at the heart of research

Radboudumc (Nijmegen)Original source
๐Ÿ‡บ๐Ÿ‡ธIndustryprotagonist-inc.com

Protagonist CEO Dinesh V. Patel and Chief Discovery Officer Ashok Bhandari Speak with BiotechTV

Protagonist TherapeuticsOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprotagonist-inc.com

Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113), a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor

Protagonist TherapeuticsOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprotagonist-inc.com

Polycythemia Vera: Mechanism of Disease

Protagonist TherapeuticsOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprotagonist-inc.com

Cancer Moonshot: How Weโ€™re Helping Patients

Protagonist TherapeuticsOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprotagonist-inc.com

BioSpace covers ICOTYDEโ„ข FDA Approval

Protagonist TherapeuticsOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

September 22, 2025 Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

Profluent | Reprogramming CRISPR Systems for Customized Genome Editing

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

January 7, 2025 Profluent Demonstrates AI Can Engineer Protein-DNA Interactions Without Iterative Laboratory Screening Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

April 16, 2025 Profluent Introduces ProGen3, Demonstrating Scaling Laws for Foundation Models in Writing Biology Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

April 22, 2024 Profluent Successfully Edits Human Genome with OpenCRISPR-1, the Worldโ€™s First AI-Created and Open-Source Gene Editor Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

March 21, 2024 Profluent Secures $35M in Additional Funding and Key Industry Experts to Scale Foundational AI Models for Biomedicine and Tackle First Vertical in Gene Editing Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

December 9, 2025 Profluent Bio Announces Strategic Collaboration with Ensoma to Develop AI-Designed Base Editors for In Vivo Hematopoietic Stem Cell Therapies Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

Profluent | Profluent Announces Strategic Partnership with Eli Lilly to Develop AI-Designed Recombinases for Genetic Medicine

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

July 30, 2025 Profluent Announces Publication of Generative AI Research in Nature with New Results for OpenCRISPR-1 Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

October 6, 2025 Profluent Announces Multi-Year Collaboration with Corteva to Accelerate Sustainable, AI-Powered Crop Innovation Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

November 17, 2025 Profluent and RSRT Partner to Tackle Rett Syndrome with AI-Designed Custom Genomic Medicines Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

October 24, 2025 Profluent and Corteva Partner to Apply AI-Designed Proteins In Agriculture Press

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

- YouTube

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

Profluent | Lilly, Profluent Ink Deal on AI Drugs Worth Up to $2.25 Billion

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

Jeff Bezos Is Backing AI Drug Development Startup Profluent

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

October 21, 2025 Integrated DNA Technologies and Profluent Forge New AI-Driven Protein Design Partnership Press

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

October 21, 2025 Integrated DNA Technologies and Profluent Collaborate to Unlock New Frontier of AI-driven Protein Design Announcement

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

April 28, 2026 Eli Lilly enlists AI startup for next-generation gene editors Press

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprofluent.bio

October 7, 2025 AI for crop engineering: Corteva, Profluent Bio partner to develop gene editing tools Press

ProfluentOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

Precision Medicine Group Launches Institute@Precision, a Collaborative Forum for Biopharma Innovation

Precision for MedicineOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

Precision for Medicine Wins Fierce CRO Award for Innovative Solutions in Drug Development

Precision for MedicineOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office

Precision for MedicineOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

Precision for Medicine Broadens Global Footprint with Singapore Office Opening

Precision for MedicineOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

Nicholas Richardson, DO, MPH, Departs FDA and Joins Precision for Medicine as VP, Clinical Development

Precision for MedicineOriginal source
๐Ÿ‡บ๐Ÿ‡ธIndustryprecisionformedicine.com

FDA Veteran Paz Vellanki, MD, PhD, Joins Precision for Medicine, Forming a Trio of Former Regulatory Leaders

Precision for MedicineOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptideโ€™s Approach to Process Intensification: Tackling the increasing Peptide Demand

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide successfully closes financial year 2025 with strong revenue growth and marked improvement in profitability

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide strengthens financing structure through expansion of existing credit facility

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide showcases leadership in sustainable peptide manufacturing with two landmark publications

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide publishes invitation to the annual General Meeting 2026

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide Group AG takes note of market rumors and speculation

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide delivers strong revenue growth and marked improvement in profitability

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide announces results of the annual General Meeting 2026

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

PolyPeptide and Lupin Manufacturing Solutions Form Strategic Alliance to Meet Growing Demand for Peptide Supply in Metabolic Therapies

PolyPeptide GroupOriginal source
๐ŸŒInvestorpolypeptide.com

Lifecore and PolyPeptide Announce Collaboration Intended to Offer End-to-End Peptide Manufacturing Solution for U.S. Market

PolyPeptide GroupOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์ด์šฉ์•ˆ๋‚ด

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์žฅ๋ก€์‹์žฅ์†Œ๊ฐœ | ๋ถ€์‚ฐ๋Œ€ํ•™๊ต๋ณ‘์›-๋ฉ”์ธ

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

๋ณ‘๋ฆฌ๊ฒ€์‚ฌ ์Šฌ๋ผ์ด๋“œ ๋ฐœ๊ธ‰

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์˜๋ฃŒ์˜์ƒ์‚ฌ๋ณธ ๋ฐœ๊ธ‰

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์˜๋ฌด๊ธฐ๋ก์‚ฌ๋ณธ ๋ฐœ๊ธ‰

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์˜ค์‹œ๋Š” ๊ธธ

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์ธต๋ณ„์•ˆ๋‚ด๋„

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

๋กœ๊ทธ์ธ | ๋ถ€์‚ฐ๋Œ€ํ•™๊ต๋ณ‘์›-๋ฉ”์ธ

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

๋ณ‘๋ฌธ์•ˆ ์•ˆ๋‚ด | ๋ถ€์‚ฐ๋Œ€ํ•™๊ต๋ณ‘์›-๋ฉ”์ธ

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

๊ฐ„ํ˜ธ๊ฐ„๋ณ‘ํ†ตํ•ฉ์„œ๋น„์Šค ์•ˆ๋‚ด

Pusan National University HospitalOriginal source
๐Ÿ‡ฐ๐Ÿ‡ทResearchpnuh.or.kr

์ž…์›์ƒํ™œ์•ˆ๋‚ด[์˜์ƒ] | ๋ถ€์‚ฐ๋Œ€ํ•™๊ต๋ณ‘์›-๋ฉ”์ธ

Pusan National University HospitalOriginal source